The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective.

导出 OA

翻译打印收藏纠错

作者： Hakan,Gunen ^[1] ; Nurdan,Kokturk ^[2] ; Sibel,Naycı ^[3] ; Sevket,Ozkaya ^[4] ; Birsen Pınar,Yıldız ^[5] ; Onur,Turan ^[6] ; Aziz,Gumus ^[7] ; Metin,Akgun ^[8] ; Alev,Gurgun ^[9] ; Candan,Ogus ^[10] ; Arzu,Mirici ^[11] ; Elif,Sen ^[12] ; Nazan,Bayram ^[13] ; Volkan,Eken ^[14] ; Hakan,Erkus ^[14]

作者单位： Department of Pulmonary Medicine, Sureyyapasa Training and Research Centre for Chest Diseases and Thoracic Surgery, Istanbul, Turkey. ^[1] Department of Pulmonary Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey. ^[2] Department of Pulmonary Medicine, Mersin University School of Medicine, Mersin, Turkey. ^[3] Department of Pulmonary Medicine, VM Medical Park Samsun Hospital, Samsun, Turkey. ^[4] University of Health Sciences, Yedikule Chest Disease and Surgery Training and Research Hospital, Pulmonology, Istanbul, Turkey. ^[5] Department of Pulmonary Medicine, Izmir Katip Çelebi University, İzmir, Turkey. ^[6] Department of Pulmonary Medicine, Recep Tayyip Erdogan University, Faculty of Medicine, Rize, Turkey. ^[7] Department of Pulmonary Medicine, Atatürk University School of Medicine, Erzurum, Turkey. ^[8] Department of Pulmonary Medicine, Ege University School of Medicine, İzmir, Turkey. ^[9] Department of Pulmonary Medicine, Akdeniz University Medical Faculty, Antalya, Turkey. ^[10] Department of Pulmonary Medicine, Canakkale 18 Mart University, Canakkale, Turkey. ^[11] Department of Pulmonary Medicine, Ankara University School of Medicine, Ankara, Turkey. ^[12] Department of Pulmonary Medicine, Gaziantep University, Sahinbey Research Hospital, Gaziantep, Turkey. ^[13] GlaxoSmithKline, Istanbul, Turkey. ^[14]

关键词 COPD COPD treatment GOLD eosinophilia exacerbation

主题词投药, 吸入(Administration, Inhalation);肾上腺皮质激素类(Adrenal Cortex Hormones);肾上腺素能β-2受体激动剂(Adrenergic beta-2 Receptor Agonists);支气管扩张药(Bronchodilator Agents);疾病恶化(Disease Progression);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);毒蕈碱拮抗剂(Muscarinic Antagonists);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);回顾性研究(Retrospective Studies)

DOI 10.2147/COPD.S372439

PMID 36003323

发布时间 2022-10-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

International journal of chronic obstructive pulmonary disease

2022年17卷

1883-1895页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective.

International journal of chronic obstructive pulmonary disease

相似文献

International journal of chronic obstructive pulmonary disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective.

International journal of chronic obstructive pulmonary disease

相似文献

International journal of chronic obstructive pulmonary disease

相关期刊

检索历史清除